Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.37 |
| ▸ | CES1 | P23141 | 3/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.33 |
| ▸ | SLC2A4 | P14672 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.32 |
| ▸ | HTR1A | P08908 | 3/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | ALB | P02768 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23272973 | 0.87 | CA2 (0.36) | CES2CES1ERN1SLC2A1SLC2A4 | |
| SCHEMBL28401102 | 0.85 | KDM4E (0.34) | CES2CES1ERN1SLC6A2HTR1A | |
| SCHEMBL29263394 | 0.85 | CA1 (0.35) | CES2CES1ERN1SLC2A1SLC2A4 | |
| SCHEMBL28855192 | 0.85 | HTR1A (0.40) | KMT2ASLC6A2HTR1ASLC6A4SLC6A3 | |
| SCHEMBL31096182 | 0.85 | HTT (0.33) | CES2CES1ERN1MAOB | |
| SCHEMBL29158156 | 0.82 | ERN1 (0.53) | CES2CES1ERN1KMT2A | |
| SCHEMBL30103308 | 0.82 | IDO1 (0.33) | KMT2AMAOB | |
| SCHEMBL30050189 | 0.82 | KMT2A (0.46) | ERN1KMT2A | |
| SCHEMBL4098184 | 0.82 | KMT2A (0.46) | ERN1KMT2A | |
| SCHEMBL29017054 | 0.82 | CYP2D6 (0.34) | KMT2ASLC6A2SLC6A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118336009-A | Phenylboronic acid-based additive and electrolyte for lithium/carbon fluoride primary battery | 上海大学 | 2024-07-12 | — | — | CN | claimed |
| CN-120136692-A | Synthesis method of nemonoxacin malate intermediate 2, 4-difluoro-3-methoxy-1-benzoic acid | 浙江昌海制药有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-118302418-B | Aromatic heterocyclic compound and application thereof | 中国科学院上海药物研究所 | 2025-05-02 | — | — | CN | disclosed |
| CN-119528713-A | Synthesis method of nemonoxacin intermediate 2, 4-difluoro-3-methoxy-1-benzoic acid | 浙江昌海制药有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-112789747-B | Organic light emitting device | 株式会社LG化学 | 2025-02-07 | — | — | CN | disclosed |
| CN-118336009-A | Phenylboronic acid-based additive and electrolyte for lithium/carbon fluoride primary battery | 上海大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-118302418-A | Aromatic heterocyclic compound and application thereof | 中国科学院上海药物研究所 | 2024-07-05 | — | — | CN | disclosed |
| CN-113946103-B | Dry film resist, method for manufacturing circuit wiring, input device, and display device | 富士胶片株式会社 | 2024-05-07 | — | — | CN | disclosed |
| CN-117044425-A | Organic light emitting device | 株式会社LG化学 | 2023-11-10 | — | — | CN | disclosed |
| CN-113631597-B | Laminate, composition, and laminate-forming kit | 富士胶片株式会社 | 2022-12-06 | — | — | CN | disclosed |
| US-7410925-B2 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-08-12 | — | — | US | disclosed |
| US-7008897-B2 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-07 | — | — | US | disclosed |
| US-20060030480-A1 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2006-02-09 | — | — | US | disclosed |
| US-20040209763-A1 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-10-21 | — | — | US | disclosed |
| EP-1167372-B1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2003-12-10 | — | — | EP | disclosed |
| US-6455720-B1 | AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-24 | — | — | US | disclosed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-0574794-B1 | Organic transition metal compound having a pi-bonding heterocyclic ligand and method of polymerizing olefins by using the same | TOSOH CORP (JP) | 2000-09-06 | — | — | EP | disclosed |
| EP-0574794-A1 | Organic transition metal compound having a pi-bonding heterocyclic ligand and method of polymerizing olefins by using the same | TOSOH CORPORATION (JP) | 1993-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | DDT, PDCD11, PLD2 | CES2 3946/4885CES1 3736/4885ERN1 3914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.